Clinical Trial Update: Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab in combination with standard chemotherapy given before surgery in breast cancer patients with low HER2 expression has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Standard chemotherapy regimen

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-04-23